The Wall Street Journal Explainer on Ibogaine for Addiction Treatment
The Wall Street Journal sent a video team to Mexico to follow an opioid use disorder patient receiving ibogaine therapy.
Texas Becomes the World Leader in Psychedelics Research
Texas Governor Greg Abbott signed a bill authorizing $50 million for clinical trials of ibogaine for the treatment of opioid use disorder.
New Documentary Shows the Miraculous Effects of Ibogaine in Treating Mental Health Disorders
A new documentary, In Waves and War, follows three retired Navy SEALs who seek out ibogaine therapy for mental health disorders.
Could DOI be the Magic Bullet? Part 3
It seems strange that DOI and/or similar and perhaps even more effective psychedelics are not already the leading anti-addiction treatments.
Could DOI Be the Magic Bullet? Part 2
We keep exploring whether 2,5-dimethoxy-4-iodoamphetamine (DOI) might be the coveted magic bullet of addiction cures.
Testing Advances on Psychedelic Therapies for Substance Use Disorders
Positive results have caused a surge in clinical trials of psychedelic substances to treat substance use disorders.